A 2021 study on rats showed that CBD helped prevent the rats from exhibiting signs of withdrawal from nicotine. Studies also show that CBD may help reduce withdrawal symptoms in people who have an addiction to certain substances. This means it may help people overcome their addiction to smoking and nicotine. One 2018 study found evidence that CBD reversed attentional bias to cigarette cues in quitting smokers compared with a placebo. Substances that have anxiolytic properties are able to prevent or treat anxiety symptoms. Studies suggest that CBD may help people quit smoking, perhaps due to its anxiolytic properties. Helping people quit smoking and dealing with withdrawal Studies suggest that CBD has anti-inflammatory properties that may help treat several conditions.Ī 2018 study in mice stated that CBD reduced inflammation by preventing the release of certain compounds that trigger inflammation.Ī 2021 review of several studies also concluded that CBD exerted a predominantly anti-inflammatory effect. Some studies suggest that CBG may provide therapeutic potential in treating:ĬBD has several possible health benefits, including the below. The substance works similarly to CBD by binding to the same receptors in the brain.Īlthough there is more research into CBD’s effects on people, research on CBG is growing. CBGĬBG is another cannabinoid present in the cannabis plant. Learn more about the benefits of CBD oil. neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease.Research also suggests that CBD may offer benefits to people with certain medical problems, such as: Imaging studies show that CBD can cause significant alterations in brain activity and connectivity patterns. It is psychoactive, but unlike THC, it does not cause the “high” sensation that many people associate with using cannabis. CBDĬBD is a cannabinoid present in the cannabis plant. Other identified cannabinoids present in cannabis include CBD and CBG. The most important psychoactive cannabinoid in cannabis is tetrahydrocannabinol (THC). The most significant compounds in cannabis are cannabinoids. Sativa contains over 400 chemical compounds, and around 80 of them are biologically active. Individuals cultivate this plant for medical purposes and for hemp, a natural textile fiber.Īccording to a 2022 article, C. Sativa), or Indian hemp, is a herbaceous plant native to central and western Asia. doi:10.1016/j. on Pinterest Jordan Siemens/Getty ImagesĬannabis sativa (C. CBG, CBD, Δ9-THC, CBN, CBGA, CBDA and Δ9-THCA as antioxidant agents and their intervention abilities in antioxidant action. doi:10.1002/prp2.682ĭawidowicz AJ, Olszowy-Tomczyk M, Typek R. Diversity of molecular targets and signaling pathways for CBD. Pharmacological aspects and biological effects of cannabigerol and its synthetic derivatives. Cannabis/marijuana use disorder.Ĭalapai F, Cardia L, Esposito E, et al. The "entourage effect": Terpenes coupled with cannabinoids for the treatment of mood disorders and anxiety disorders. doi:10.1021/acsinfecdis.9b00419įerber SG, Namdar D, Hen-Shoval D, et al. Uncovering the hidden antibiotic potential of cannabis. University of Northern Colorado.įarha MA, El-Halfawy OM, Gale RT, et al. Meta-analysis of cannabigerol effects of breast cancer tissue cells. A systematic review of minor phytocannabinoids with promising neuroprotective potential. Stone NL, Murphy AJ, England TJ, O'Sullivan SE. Handbook of Cannabis and Related Pathologies. Chapter 77 - Cannabinoid regulation of intraocular pressure: Human and animal studies, cellular and molecular targets. Glaucoma and eye pressure.Īloway A, Kumar A, Laun AS, Song ZH. The use of cannabinoids in the treatment of inflammatory bowel disease (IBD): A review of the literature. ![]() Nduma BN, Mofor KA, Tatang J, Ekhator C, Ambe S, Fonkem E. Chronic pain among adults - United States, 2019-2021. ![]() doi:10.1089/can.2021.0058Ĭenters for Disease Control and Prevention. Survey of patients employing cannabigerol-predominant cannabis preparations: Perceived medical effects, adverse events, and withdrawal symptoms. Russo EB, Cuttler C, Cooper ZD, Stueber A, Whiteley VL, Sexton M. The origin and biomedical relevance of cannabigerol. Jastrząb A, Jarocka-Karpowicz I, Skrzydlewska E. ![]() Chemometric analysis of cannabinoids: Chemotaxonomy and domestication syndrome. In vitro and clinical evaluation of cannabigerol (CBG) produced via yeast biosynthesis: A cannabinoid with a broad range of anti-inflammatory and skin health-boosting properties. Perez E, Fernandez JR, Fitzgerald C, Rouzard K, Tamura M, Savile C.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |